Impact of resistance mutations in a context of low-level HIV viremia

被引：0
|
作者：
Wirden, M. [1 ]
Valantin, M. A. [1 ]
Tubiana, R. [1 ]
Simon, A. [1 ]
Soulie, C. [1 ]
Todesco, E. [1 ]
Katlama, C. [1 ]
Calvez, V. [1 ]
Marcelin, A. G. [1 ]
Lambert-Niclot, S. [1 ]
机构：
[1] Univ Paris 06, Hop Pitie Salpetriere, AP HP,Pierre Louis Inst Epidemiol & Publ Hlth, INSERM,UMR S 1136, F-75013 Paris, France
来源：
ANTIVIRAL THERAPY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
96
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [41] Durable HIV treatment benefit despite low-level viremia - Reassessing definitions of success or failure
    Deeks, SG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02): : 224 - 226
  • [42] Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women
    Delwart, Eric
    Bernardin, Flavien
    Lee, Tzong-Hae
    Winkelman, Valerie
    Liu, Chenglong
    Sheppard, Haynes
    Liu, Albert
    Greenblatt, Ruth
    Anastos, Katryn
    DeHovitz, Jack
    Nowicki, Marek
    Cohen, Mardge
    Golub, Elizabeth T.
    Barbour, Jason
    Buchbinder, Susan
    Busch, Michael P.
    AIDS, 2011, 25 (05) : 619 - 623
  • [43] Persistent low-level viremia may increase the risk of cardiovascular disorders in people living with HIV
    Lara-Aguilar, V.
    Brochado-Kith, O.
    Crespo-Bermejo, C.
    Llamas-Adan, M.
    Grande-Garcia, S.
    Arca-de la Fuente, S.
    Deza-De La Casa, A.
    Martin-Carbonero, L.
    de los Santos, I.
    Madrid, R.
    Fernandez-Rodriguez, A.
    Briz, V.
    HIV MEDICINE, 2023, 24 : 273 - 275
  • [44] Low-Level Viremia in HIV-1 Infection: Consequences and Implications for Switching to a New Regimen
    Cohen, Calvin
    HIV CLINICAL TRIALS, 2009, 10 (02): : 116 - 124
  • [45] Analysis of virologic outcome in low-level HIV-1 viremia patients in a small cohort
    Ding, Lisha
    Chen, Xi
    He, Jianmei
    Zheng, Jun
    Wei, Xiuqing
    Qin, Biyun
    Li, Xiangzhong
    FUTURE VIROLOGY, 2022, 17 (09) : 627 - 632
  • [46] Clinical significance and management of low-level HIV viremia in the era of integrase strand transfer inhibitors
    Shi, Jinchuan
    Ying, Gaoxiang
    Zheng, Rongrong
    Zhang, Zhongdong
    HIV MEDICINE, 2024, 25 (03) : 361 - 369
  • [47] Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis
    Wong, Sharon Y.
    Lee, Jong Seok
    Kwak, Hyun Kyung
    Via, Laura E.
    Boshoff, Helena I. M.
    Barry, Clifton E., III
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2515 - 2522
  • [48] HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China
    Li, Qun
    Yu, Fengting
    Song, Chuan
    Zhao, Hongxin
    Xiao, Qing
    Lao, Xiaojie
    Yang, Siyuan
    Tang, Yunxia
    Zhang, Fujie
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 6711 - 6722
  • [49] The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
    Inzaule, Seth C.
    Bertagnolio, Silvia
    Kityo, Cissy M.
    Siwale, Margaret
    Akanmu, Sulaimon
    Wellington, Maureen
    de Jager, Marleen
    Ive, Prudence
    Mandaliya, Kishor
    Stevens, Wendy
    Boender, Tamara S.
    Ondoa, Pascale
    Sigaloff, Kim C. E.
    de Wit, Tobias F. Rinke
    Hamers, Raph L.
    AIDS, 2020, 34 (10) : 1559 - 1566
  • [50] Association between differentiated HIV care delivery model and low-level viremia among people living with HIV in Rwanda
    Sebeza, Jackson
    Mbwana, Mariam. S.
    Ramadhani, Habib. O.
    Ally, Zuhura M.
    Lascko, Taylor
    Memiah, Peter
    Tuyishime, Simeon
    Rwibasira, Galican
    AIDS RESEARCH AND THERAPY, 2024, 21 (01):
12345